The global AI in pathology market is on track to grow from $168.25 million in 2025 to $1.15 billion by 2033, a compound annual growth rate of 27.42%, according to a recent industry analysis. The expansion is driven by the push toward precision medicine, the increasing prevalence of chronic diseases, and the digital overhaul of pathology laboratories.
AI models deliver higher accuracy in tissue analysis
In July 2025, LG AI Research released the EXAONE Path 2.0 model, designed to improve cancer diagnosis and drug development. The system analyzes whole slide images alongside smaller tissue patches, preserving detailed contextual data. It achieved a prediction accuracy of 78.4% based on multi-omics data, showing how AI can integrate histopathological images with genomic information to refine disease subtyping and prognosis.
Investment and industry partnerships propel adoption
Funding rounds and strategic collaborations are accelerating the deployment of AI-driven pathology tools. Proscia raised $50 million to scale its Concentriq platform, which uses AI to manage and analyze pathology data. Partnerships with original equipment manufacturers such as Agilent Technologies and Siemens Healthineers are embedding AI capabilities deeper into laboratory workflows. In April 2025, Precision for Medicine and PathAI joined forces to develop advanced digital pathology capabilities for clinical trials. The collaboration integrates PathAI's AISight system to enhance biospecimen analysis, aiming for greater data consistency and reliability.
Automation reduces manual tasks and human error
AI automation is taking over repetitive tasks like tissue segmentation and cell counting, which cuts down on human error and frees pathologists to focus on complex cases. Owkin's AI solutions, for example, streamline diagnostics, improve biomarker screening, and predict patient outcomes in precision oncology. The rise of telepathology, combined with these workflow improvements, is helping laboratories achieve higher operational efficiency even as caseloads grow.
As digital pathology becomes mainstream, many healthcare organizations are investing in workforce training to keep pace. Resources such as AI for Healthcare Courses & Certifications offer structured learning paths for professionals adapting to AI-integrated diagnostics.
Why this matters for healthcare professionals
For pathologists, lab managers, and clinical researchers, the shift toward AI-assisted analysis means that routine diagnostic work will increasingly rely on algorithmic support. Staying current with these tools is no longer optional-it is becoming a core competency. The market's rapid growth signals that AI will soon be a standard layer in pathology workflows, and those who understand how to validate and deploy these systems will be best positioned to improve patient outcomes and operational efficiency.
Your membership also unlocks:
